Rituximab-Bendamustine (R-Benda) in MALT Lymphoma Complicating Primary Sjögren Syndrome (pSS)

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15120
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Rituximab Alone (R) Versus Rituximab Plus Bendamustine (Br) for Splenic (Smzl) and Nodal Marginal Zone Lymphoma (Nmzl)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology
Hematology
2018English

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology
Hematology
2018English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B- And T-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Multisystem Presentation of Primary Sjögren Syndrome

CMAJ
Medicine
2019English

Adult Atypical Sporadic Burkitt Lymphoma Successfully Treated With Bendamustine and Rituximab

Lymphoma and Chronic Lymphocytic Leukemias
2013English

Differences in Quality of Life Between Bendamustine-Rituximab and R-Chop/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2016English

Pulmonary MALT Lymphoma in Patients With Sjögren’s Syndrome

Clinical Medicine and Research
MedicineHome CareCommunity
2017English

Primary Diffuse Large B-Cell Lymphoma of the Bone: Bendamustine and Rituximab Are Able to Overcome Resistant Disease

SpringerPlus
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy